Objective
Neurodegenerative diseases present a broad range of phenotypic symptoms derived from deterioration of different brain functions, such as controlling movements, processing information or memory. All those symptoms are caused by the loss of specific neurons controlling those processes. All neurodegenerative diseases result from damage of neurons or their myelin sheaths that eventually will lead to dysfunction and disabilities. The neuroinflammatory hypothesis of neurodegenerative diseases proposes that inflammation contributes to their pathogenesis. Recent studies have provided information of the direct role of prolyl oligopeptidse (POP) and its specific inhibitors in toxic neuroinflammatory responses, since has been observed that POP is 1) mediator of human microglial neurotoxicity, 2) it is involved in the production of chemoattractants and proinflammatory chemokines derived from collagen and 3) in vitro POP substrates ameliorates behavioural deficits in Alzheimer’s disease models by reducing neuroinflammatory responses. The project aims to contribute to the knowledge on the molecular mechanism involving POP and its inhibitors in the frame of inflammation and neurodegeneration, with the last objective of promoting therapeutic applicability of POP inhibitors. The proposal implementation will consider different approaches, such as clinical and biochemical and pharmacological studies in cell cultures and animal models. During the carry out of the project, we will measure POP activity and protein levels from patients suffering neurodegenerative diseases as well as we will evaluate the endogenous POP inhibitor. In addition, we will test the impact of POP inhibitors on induced neurotoxicity cell cultures and on the pathology progression of animal models. The proposal promises to generate applicable research, strengthen collaborative agreements and promote the convergence of efforts to increase the European competitiveness.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- natural sciences biological sciences neurobiology
- medical and health sciences basic medicine neurology dementia alzheimer
- natural sciences biological sciences biochemistry biomolecules proteins
- medical and health sciences basic medicine pathology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2009-IEF
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
00014 HELSINGIN YLIOPISTO
Finland
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.